Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes

被引：5

作者：

Criego, Amy B. ^{[1
]}

Carlson, Anders L. ^{[2
]}

Brown, Sue A. ^{[3
]}

Forlenza, Gregory P. ^{[4
]}

Bode, Bruce W. ^{[5
]}

Levy, Carol J. ^{[6
]}

Hansen, David W. ^{[7
]}

Hirsch, Irl B. ^{[8
]}

Bergenstal, Richard M. ^{[2
]}

Sherr, Jennifer L. ^{[9
]}

Mehta, Sanjeev N. ^{[10
]}

Laffel, Lori M. ^{[10
]}

Shah, Viral N. ^{[4
]}

Bhargava, Anuj ^{[11
]}

Weinstock, Ruth S. ^{[12
]}

Macleish, Sarah A. ^{[13
]}

Desalvo, Daniel J. ^{[14
]}

Jones, Thomas C. ^{[15
]}

Aleppo, Grazia ^{[16
]}

Buckingham, Bruce A. ^{[17
]}

Ly, Trang T. ^{[18
,19
]}

机构：

[1] Int Diabet Ctr, Dept Pediat Endocrinol, Pk Nicollet, Minneapolis, MN USA

[2] Int Diabet Ctr, HealthPartners, Pk Nicollet, Minneapolis, MN USA

[3] Univ Virginia, Ctr Diabet Technol, Div Endocrinol, Charlottesville, VA USA

[4] Univ Colorado, Barbara Davis Ctr Diabet, Dept Pediat, Anschutz Med Campus, Aurora, CO USA

[5] Atlanta Diabet Associates, Atlanta, GA USA

[6] Icahn Sch Med Mt Sinai, Div Endocrinol Diabet & Metab, New York, NY USA

[7] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA

[8] Univ Washington, Dept Med, Seattle, WA USA

[9] Yale Sch Med, Dept Pediat, New Haven, CT USA

[10] Joslin Diabet Ctr, Harvard Med Sch, Boston, MA USA

[11] Iowa Diabet Res, W Des Moines, IA USA

[12] SUNY Upstate Med Univ, Dept Med, Syracuse, NY USA

[13] Univ Hosp Cleveland Med Ctr, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH USA

[14] Baylor Coll Med, Dept Pediat, Houston, TX USA

[15] Jones Ctr, East Coast Inst Res, Dept Res, Macon, GA USA

[16] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL USA

[17] Stanford Univ, Dept Pediat, Div Pediat Endocrinol, Stanford, CA USA

[18] Insulet Corp, Acton, MA USA

[19] Insulet Corp, Clin Affairs, 100 Nagog Pk, Acton, MA 01720 USA

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2024年 / 26卷 / 01期

关键词：

Type; 1; diabetes; Artificial pancreas; Insulin pumps; Clinical trials; Closed-loop systems;

D O I：

10.1089/dia.2023.0364

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: The Omnipod (R) 5 Automated Insulin Delivery (AID) System was shown to be safe and effective following 3 months of use in people with type 1 diabetes (T1D); however, data on the durability of these results are limited. This study evaluated the long-term safety and effectiveness of Omnipod 5 use in people with T1D during up to 2 years of use.Materials and Methods: After a 3-month single-arm, multicenter, pivotal trial in children (6-13.9 years) and adolescents/adults (14-70 years), participants could continue system use in an extension phase. HbA1c was measured every 3 months for up to 15 months; continuous glucose monitor metrics were collected for up to 2 years.Results: Participants (N = 224) completed median (interquartile range) 22.3 (21.7, 22.7) months of AID. HbA1c was reduced in the pivotal trial from 7.7% +/- 0.9% in children and 7.2% +/- 0.9% in adolescents/adults to 7.0% +/- 0.6% and 6.8% +/- 0.7%, respectively, (P < 0.0001), and was maintained at 7.2% +/- 0.7% and 6.9% +/- 0.6% after 15 months (P < 0.0001 from baseline). Time in target range (70-180 mg/dL) increased from 52.4% +/- 15.6% in children and 63.6% +/- 16.5% in adolescents/adults at baseline to 67.9% +/- 8.0% and 73.8% +/- 10.8%, respectively, during the pivotal trial (P < 0.0001) and was maintained at 65.9% +/- 8.9% and 72.9% +/- 11.3% during the extension (P < 0.0001 from baseline). One episode of diabetic ketoacidosis and seven episodes of severe hypoglycemia occurred during the extension. Children and adolescents/adults spent median 96.1% and 96.3% of time in Automated Mode, respectively.Conclusion: Our study supports that long-term use of the Omnipod 5 AID System can safely maintain improvements in glycemic outcomes for up to 2 years of use in people with T1D.Clinical Trials Registration Number: NCT04196140

引用

页码：11 / 23

页数：13

共 50 条

[41] Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial
Fox, D. Steven
Ware, Julia
Boughton, Charlotte K.
Allen, Janet M.
Wilinska, Malgorzata E.
Tauschmann, Martin
Denvir, Louise
Thankamony, Ajay
Campbell, Fiona
Wadwa, R. Paul
Buckingham, Bruce A.
Davis, Nikki
Dimeglio, Linda A.
Mauras, Nelly
Besser, Rachel E. J.
Ghatak, Atrayee
Weinzimer, Stuart A.
Kanapka, Lauren
Kollman, Craig
Sibayan, Judy
Beck, Roy W.
Hood, Korey K.
Hovorka, Roman
[J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024,
[42] Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial
Hovorka, Roman
Allen, Janet M.
Elleri, Daniela
Chassin, Ludovic J.
Harris, Julie
Xing, Dongyuan
Kollman, Craig
Hovorka, Tomas
Larsen, Anne Mette F.
Nodale, Marianna
De Palma, Alessandro
Wilinska, Malgorzata E.
Acerini, Carlo L.
Dunger, David B.
[J]. LANCET, 2010, 375 (9716): : 743 - 751
[43] Automated insulin delivery use in adults with type 1 diabetes not meeting glycaemic targets despite treatment with insulin pump and CGM: a randomised controlled trial
Christensen, M. B.
Ranjan, A. G.
Rytter, K.
McCarthy, O. M.
Schmidt, S.
Norgaard, K.
[J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S386 - S386
[44] Continuous vs. Intermittent Insulin Delivery in Children and Adolescents with Type 1 Diabetes Mellitus
Joseph L. Mathew
Rakesh Kumar
Deepika Harit
[J]. Indian Pediatrics, 2019, 56 : 595 - 602
[45] Continuous vs. Intermittent Insulin Delivery in Children and Adolescents with Type 1 Diabetes Mellitus
Mathew, Joseph L.
Kumar, Rakesh
Harit, Deepika
[J]. INDIAN PEDIATRICS, 2019, 56 (07) : 595 - 602
[46] Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 Diabetes
Levy, Carol J.
Bailey, Ryan
Laffel, Lori M.
Forlenza, Gregory
DiMeglio, Linda A.
Hughes, Michael S.
Brown, Sue A.
Aleppo, Grazia
Bhargava, Anuj
Shah, Viral N.
Clements, Mark A.
Kipnes, Mark
Bruggeman, Brittany
Daniels, Mark
Rodriguez, Henry
Calhoun, Peter
Lum, John W.
Sasson-Katchalski, Ravid
Pinsker, Jordan E.
Pollom, Robyn
Beck, Roy W.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (09) : 652 - 660
[47] Use of a decision support tool and quick start onboarding tool in individuals with type 1 diabetes using advanced automated insulin delivery: a single-arm multi-phase intervention study
Sehgal, Shekhar
De Bock, Martin
Grosman, Benyamin
Williman, Jonathan
Kurtz, Natalie
Guzman, Vanessa
Benedetti, Andrea
Roy, Anirban
Turksoy, Kamuran
Juarez, Magaly
Jones, Shirley
Frewen, Carla
Watson, Antony
Taylor, Barry
Wheeler, Benjamin J.
[J]. BMC ENDOCRINE DISORDERS, 2024, 24 (01)
[48] Automated Insulin Delivery Around Exercise in Adults with Type 1 Diabetes: A Pilot Randomized Controlled Study
McCarthy, Olivia M.
Christensen, Merete B.
Kristensen, Kasper Birch
Schmidt, Signe
Ranjan, Ajenthen G.
Bain, Stephen C.
Bracken, Richard M.
Norgaard, Kirsten
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (07) : 476 - 484
[49] Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial
Burnside, Mercedes J. J.
Lewis, Dana M. M.
Crocket, Hamish R. R.
Meier, Renee A. A.
Williman, Jonathan A. A.
Sanders, Olivia J. J.
Jefferies, Craig A. A.
Faherty, Ann M. M.
Paul, Ryan G. G.
Lever, Claire S. S.
Price, Sarah K. J.
Frewen, Carla M. M.
Jones, Shirley D. D.
Gunn, Tim C. C.
Lampey, Christina
Wheeler, Benjamin J. J.
de Bock, Martin I. I.
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (04) : 250 - 259
[50] Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes
Biester, Torben
Danne, Thomas
Blaesig, Sarah
Remus, Kerstin
Aschemeier, Baerbel
Kordonouri, Olga
Bardtrum, Lars
Haahr, Hanne
[J]. PEDIATRIC DIABETES, 2016, 17 (08) : 642 - 649

← 1 2 3 4 5 →